Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.

Cammu, G; de Kam, P-J; De Graeve, K; van den Heuvel, M; Suy, K; Morias, K; Foubert, L; Grobara, P; Peeters, P

Cammu, G; de Kam, P-J; De Graeve, K; van den Heuvel, M; Suy, K; Morias, K; Foubert, L; Grobara, P; Peeters, P.

Affiliation

Cammu G; Department of Anaesthesiology and Critical Care Medicine, Onze-Lieve-Vrouw Ziekenhuis, Moorselbaan 164, 9300 Aalst, Belgium. guy.cammu@olvz-aalst.be

Br J Anaesth ; 105(4): 487-92, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20630888

Subject(s)

Androstanols/administration & dosage; Neuromuscular Junction/drug effects; Neuromuscular Nondepolarizing Agents/administration & dosage; gamma-Cyclodextrins/pharmacology; Adolescent; Adult; Androstanols/antagonists & inhibitors; Androstanols/pharmacology; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Models, Biological; Neuromuscular Blockade/methods; Neuromuscular Junction/physiology; Neuromuscular Nondepolarizing Agents/antagonists & inhibitors; Neuromuscular Nondepolarizing Agents/pharmacology; Pilot Projects; Rocuronium; Sugammadex; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Neuromuscular Nondepolarizing Agents / Gamma-Cyclodextrins / Androstanols / Neuromuscular Junction Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google